“More clinical trials have moved to India and China, but one thing we might think about is the way we market and involve patients, that’s right involve patients and their doctors. The first move here is to have information, something that has been lacking, and not just a software company with a data base of eligible patients calling and doing blast emails, or trying to get “social” through the social networks on the web. Not to knock social networks in this effort as they can be helpful for folks comparing notes, and please by all means, use an alias for your own sake too.”
Article
The Medical Quack, 16 March 2009
